NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of MiMedx Group, Inc. (NASDAQ: MDXG) resulting from allegations that management may have issued materially misleading business information to the investing public.
On June 7, 2018, MiMedx disclosed that: (1) its previously issued consolidated financial statements for the fiscal years ended December 31, 2012, 2013, 2014, 2015, and 2016 and each of the interim periods ended March 31, June 30, and September 2017 should be restated; (2) all communications and financial information related to the fourth quarter of 2017 and first quarter of 2018 should no longer be relied upon; and (3) guidance for the 2018 fiscal year was withdrawn. MiMedx also disclosed that the individuals serving as the company’s Chief Financial Officer and Corporate Controller left those roles effective June 6, 2018, and that the Chief Accounting Officer position remained vacant.
If you currently own shares of MiMedx, please visit the firm’s website at http://www.rosenlegal.com/cases-198.html or more information. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.